Literature DB >> 27139932

A Method-bridging Study for Serum 25-hydroxyvitamin D to Standardize Historical Radioimmunoassay Data to Liquid Chromatography-Tandem Mass Spectrometry.

Rosemary L Schleicher, Maya R Sternberg, David A Lacher, Christoher T Sempos, Anne C Looker, Ramon A Durazo-Arvizu, Elizabeth A Yetley, Madhulika Chaudhary-Webb, Khin L Maw, Christine M Pfeiffer, Clifford Johnson.   

Abstract

BACKGROUND: Serum concentrations of 25-hydroxyvitamin D (25OHD) were measured for the National Health and Nutrition Examination Survey (NHANES) over the 1988-2006 period using a radioimmunoassay (RIA). In 2010, the Centers for Disease Control and Prevention (CDC) reissued RIA-harmonized 25OHD for NHANES 2004 and 2006, and advised users to adjust the original RIA data from 1988-1994 by using an equation. Beginning with NHANES 2007-2008, a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method measured 25OHD.
METHODS: A method comparison (bridging) study was designed to convert original RIA 25OHD to LC–MS/MS-equivalents. This report compares the predictive ability of a competitor regression model (Model 2) to the equations that CDC publicly released in 2015 (Model 1). The models differ by time period variable and use of transformations.
RESULTS: The two models provided similar adjusted R(2) (Model 1: 88.9%, Model 2: 90.4%) and root mean square error of prediction (plus or minus 9 to 10 nanomoles per liter [nmol/L]). Applying these models to NHANES 1988–2006 RIA 25OHD, the Pearson correlation of LC–MS/MS-equivalent concentrations was 0.99; the median difference between models was 0 nmol/L (interquartile range: –2.8 to 1 nmol/L). In contrast to declining RIA-harmonized 25OHD, both models showed little change in LC–MS/MS-predicted 25OHD over the 1988–2006 period. For 2001–2006, both models predicted similar prevalences of 25OHD less than 30 nmol/L, which were lower than the prevalence estimates based on RIA-harmonized data. Mean weighted LC–MS/MS-equivalent concentrations based on either model were about 3 nmol/L lower for the 1988–1994 survey and about 3 nmol/L higher for the 2001–2006 surveys, effectively smoothing out temporal trends observed using the harmonized RIA data.
CONCLUSIONS: Given minimal differences between models, final selection was based on public availability of the regression data. The bridging equations provide a way to use the previous RIA results to obtain LC–MS/MS-equivalent concentrations and evaluate temporal trends in vitamin D status. All material appearing in this report is in the public domain and may be reproduced or copied without permission; citation as to source, however, is appreciated.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27139932

Source DB:  PubMed          Journal:  Natl Health Stat Report        ISSN: 2164-8344


  19 in total

Review 1.  Vitamin D assays and the definition of hypovitaminosis D: results from the First International Conference on Controversies in Vitamin D.

Authors:  Christopher T Sempos; Annemieke C Heijboer; Daniel D Bikle; Jens Bollerslev; Roger Bouillon; Patsy M Brannon; Hector F DeLuca; Glenville Jones; Craig F Munns; John P Bilezikian; Andrea Giustina; Neil Binkley
Journal:  Br J Clin Pharmacol       Date:  2018-07-17       Impact factor: 4.335

2.  Cost effective measures to standardize serum 25(OH)D values from completed studies.

Authors:  C T Sempos; R A Durazo-Arvizu; G D Carter
Journal:  Osteoporos Int       Date:  2017-03-20       Impact factor: 4.507

Review 3.  Challenges and Lessons Learned in Generating and Interpreting NHANES Nutritional Biomarker Data.

Authors:  Christine M Pfeiffer; David A Lacher; Rosemary L Schleicher; Clifford L Johnson; Elizabeth A Yetley
Journal:  Adv Nutr       Date:  2017-03-15       Impact factor: 8.701

4.  The vitamin D status of the US population from 1988 to 2010 using standardized serum concentrations of 25-hydroxyvitamin D shows recent modest increases.

Authors:  Rosemary L Schleicher; Maya R Sternberg; David A Lacher; Christopher T Sempos; Anne C Looker; Ramon A Durazo-Arvizu; Elizabeth A Yetley; Madhulika Chaudhary-Webb; Khin L Maw; Christine M Pfeiffer; Clifford L Johnson
Journal:  Am J Clin Nutr       Date:  2016-07-06       Impact factor: 7.045

5.  Vitamin D Pathway and Other Related Polymorphisms and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial.

Authors:  Kathleen Torkko; Cathee Till; Catherine M Tangen; Phyllis J Goodman; Xiaoling Song; Jeannette M Schenk; M Scott Lucia; Ulrike Peters; Adrie van Bokhoven; Ian M Thompson; Marian L Neuhouser
Journal:  Cancer Prev Res (Phila)       Date:  2020-02-26

6.  The Reverse J-Shaped Association Between Serum Total 25-Hydroxyvitamin D Concentration and All-Cause Mortality: The Impact of Assay Standardization.

Authors:  Ramón A Durazo-Arvizu; Bess Dawson-Hughes; Holly Kramer; Guichan Cao; Joyce Merkel; Paul M Coates; Christopher T Sempos
Journal:  Am J Epidemiol       Date:  2017-04-15       Impact factor: 4.897

7.  Vitamin D status in the United States, 2011-2014.

Authors:  Kirsten A Herrick; Renee J Storandt; Joseph Afful; Christine M Pfeiffer; Rosemary L Schleicher; Jaime J Gahche; Nancy Potischman
Journal:  Am J Clin Nutr       Date:  2019-07-01       Impact factor: 7.045

8.  Multiple imputation to evaluate the impact of an assay change in national surveys.

Authors:  Maya Sternberg
Journal:  Stat Med       Date:  2017-04-16       Impact factor: 2.373

9.  Limitations of platform assays to measure serum 25OHD level impact on guidelines and practice decision making.

Authors:  Maya Rahme; Laila Al-Shaar; Ravinder Singh; Rafic Baddoura; Georges Halaby; Asma Arabi; Robert H Habib; Rose Daher; Darina Bassil; Karim El-Ferkh; Maha Hoteit; Ghada El-Hajj Fuleihan
Journal:  Metabolism       Date:  2018-09-15       Impact factor: 8.694

10.  Sex-specific 25-hydroxyvitamin D threshold concentrations for functional outcomes in older adults: PRoject on Optimal VItamin D in Older adults (PROVIDO).

Authors:  Michelle Shardell; Anne R Cappola; Jack M Guralnik; Gregory E Hicks; Stephen B Kritchevsky; Eleanor M Simonsick; Luigi Ferrucci; Richard D Semba; Nancy Chiles Shaffer; Tamara Harris; Gudny Eiriksdottir; Vilmundur Gudnason; Mary Frances Cotch; Eric Orwoll; Kristine E Ensrud; Peggy M Cawthon
Journal:  Am J Clin Nutr       Date:  2021-07-01       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.